Contact Information

For more information, please contact  Mattie L. Shepheard at 212.297.0857 or ShepheardM@NJHealth.org.

 

For 115 Years, the Leading Respiratory Hospital in the Nation

National Jewish Health is the leading respiratory hospital in the nation. Founded 115 years ago as a nonprofit hospital, National Jewish Health today is the only facility in the world dedicated exclusively to groundbreaking medical research and treatment of patients with respiratory, cardiac, immune and related disorders. Patients and families come to National Jewish Health from around the world to receive cutting-edge, comprehensive, coordinated care.


LUNGLINE® (800.222.LUNG) - our free help line staffed by registered nurses - has answered more than 1.35 million calls and emails since it was established in 1983.
 

A Few Facts About Asthma

  • Asthma affects more than 34 million Americans, nearly 9.6 million of whom are children, making asthma the most common chronic childhood illness.
  • Asthma prevalence has increased 75 percent in the last 20 years, and continues to rise, especially in children.
  • Asthma is the third ranking cause of hospitalization among children under the age of 15; it is the first ranking cause among chronic conditions.
  • Asthma is the number one cause of school absences attributed to a chronic condition – more than 14 million school days are missed every year as a result of asthma.
  • Direct health care costs for asthma in the United States total more than $30 billion annually. More than 3,400 adults and 250 children in the United States die each year from asthma.

 

The Fund to Cure Asthma

Impressed by the level of excellence at National Jewish Health and motivated by firsthand experiences of the devastating effects of asthma, the founders of The Fund to Cure Asthma set a goal of raising $14 million to strengthen the research efforts at National Jewish Health. The goal includes endowing six department chairs:  Pediatric Asthma, Adult Asthma, Asthma Research, Pediatric Allergy, Adult Allergy and Basic Immunology, thus helping to ensure that National Jewish Health will stay at the forefront of asthma research and treatment.